| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 04/15/1999 | WO1998045322A3 Diagnosis method and reagents |
| 04/15/1999 | CA2305689A1 Secreted proteins and polynucleotides encoding them |
| 04/15/1999 | CA2305688A1 Methods and compositions for treating rheumatoid arthritis |
| 04/14/1999 | EP0907887A1 Engineering affinity ligands for macromolecules |
| 04/14/1999 | EP0907658A1 Neuropeptide y agonists |
| 04/14/1999 | EP0907370A1 Hla-a2.1 binding peptides and their uses |
| 04/14/1999 | EP0907368A1 Novel heparin binding peptides |
| 04/14/1999 | EP0907348A1 Tooth-cleaning agent in granular form |
| 04/14/1999 | EP0907312A1 Compositions and methods for taxol biosynthesis |
| 04/14/1999 | EP0787140A4 Process for performing retro-aldol reaction |
| 04/14/1999 | EP0759934B1 Neurotensin antagonist peptides |
| 04/14/1999 | EP0669938B1 PEPTIDE DERIVATIVES OF $g(a)-MSH AND THEIR APPLICATION |
| 04/14/1999 | EP0621789B1 Pharmaceutical pentapeptide compositions and methods of use thereof |
| 04/14/1999 | CN1214051A Induction of immune responese against desired determinants |
| 04/08/1999 | WO1999016791A2 Compounds and methods for regulating cell adhesion |
| 04/08/1999 | WO1999016459A1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 04/08/1999 | WO1999016409A2 Gene therapy approaches to supply apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 04/08/1999 | WO1998056919A9 Methods and reagents for vaccination which generate a cd8 t cell immune response |
| 04/08/1999 | CA2304814A1 Gene therapy approaches to supply apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 04/08/1999 | CA2304805A1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 04/07/1999 | EP0906919A2 Novel integrin-binding peptides |
| 04/07/1999 | EP0906915A1 Preparation of cyclic peptide antifungal agents |
| 04/07/1999 | EP0906419A2 Peptide ligands of the urokinase receptor |
| 04/07/1999 | EP0906337A2 AN ANTIGENIC EPITOPE OF THE u A /u DETERMINANT OF HEPATITIS B SURFACE ANTIGEN AND USES THEREOF |
| 04/07/1999 | EP0906336A1 Antibiotic producing microbe |
| 04/07/1999 | EP0906335A1 Ebv ctl epitopes |
| 04/07/1999 | EP0906334A1 Auto-deconvoluting combinatorial libraries |
| 04/07/1999 | EP0906333A2 Substrates and inhibitors of proteolytic enzymes |
| 04/07/1999 | EP0625164B1 CYCLIC COMPOUNDS USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa |
| 04/07/1999 | CN1213406A Method for inhibiting adenylosuccinate synthetase activity methylthioadenosine phosphorylasse deficient cells |
| 04/07/1999 | CN1213380A Peptide immunogens for vaccination against and treatment of allergy |
| 04/07/1999 | CN1213379A Peptide derivatives |
| 04/06/1999 | US5891995 Allowing conversion from stable form to labile form for cleavage of peptide from support under mild conditions after deprotection of amino acid side chains |
| 04/06/1999 | US5891994 Peptides and polypeptides which induce antibodies against hiv-1 tat proteins; for vaccines; diagnosis |
| 04/06/1999 | US5891993 Template assembled synthetic protein |
| 04/06/1999 | US5891869 Basic oxazoline-amide derivatives of GE2270 and GE2270-like antibiotics |
| 04/06/1999 | US5891851 Antibiotic, feglymycin, processes for its preparation and its use |
| 04/06/1999 | US5891695 Polypeptides involved in the biosynthesis of streptogramins, nucleotide sequences coding for these polypeptides and their use |
| 04/06/1999 | US5891652 Methods of using domains of extracellular region of human platelet-derived growth factor receptor polypeptides |
| 04/06/1999 | US5891640 Peptide derived from human immunodeficiency virus type 1 (HIV-1), isolate ant70, containing an immunodominant epitope and it's use in immunodiagnostic assays |
| 04/06/1999 | US5891436 The present invention thus provides the basis of an extremely sensitive and specific diagnostic elisa for anti-70 kd antibodies found in pbc. |
| 04/06/1999 | US5891341 Compositions and devices for partitioning advanced glycosylation endproducts, and methods of their use |
| 04/06/1999 | CA2074320C Process for the preparation of microspheres made of a biodegradable polymeric material |
| 04/06/1999 | CA1340485C Peptide analogs and their use as haptens to elicit catalytic antibodies |
| 04/01/1999 | WO1999015552A1 Oligopeptide compounds |
| 04/01/1999 | WO1999015551A1 Novel receptor |
| 04/01/1999 | WO1999015550A1 Ucp3 genes |
| 04/01/1999 | WO1999015549A2 Peptide sequences as hinge regions in proteins like immunoglobulin fragments and their use in medicine |
| 04/01/1999 | WO1999015130A2 Synthetic antineoplastic agents derived from dolastatin 15 and methods of making same |
| 04/01/1999 | WO1999010373B1 Non-immunosuppressive cyclosporins and their use in the prevention and treatment of hiv infection |
| 04/01/1999 | WO1998054577A9 Cyclic peptide libraries and methods of use thereof to identify binding motifs |
| 04/01/1999 | WO1998014592A3 Telomerase reverse transcriptase |
| 04/01/1999 | DE19740310A1 Peptid mit Affinität zu Gerinnungsfaktor VIII A peptide having affinity for coagulation factor VIII |
| 04/01/1999 | CA2303003A1 Ucp3 genes |
| 04/01/1999 | CA2271700A1 G-protein-coupled receptor tsr32 |
| 03/31/1999 | EP0905518A1 Peptides specific for gluten-sensitive T-cells and use thereof |
| 03/31/1999 | EP0905246A1 Cloning of chicken anaemia DNA |
| 03/31/1999 | EP0904541A1 PURIFICATION OF TISSUE PLASMINOGEN ACTIVATOR (tPA) |
| 03/31/1999 | EP0904539A1 Inhibiting protein interactions |
| 03/31/1999 | EP0904402A1 Interaction trap systems for detecting protein interactions |
| 03/31/1999 | EP0904294A1 Conjugates of lipophilic moieties and fragments of vasoactive intestinal peptide (vip) |
| 03/31/1999 | EP0904285A1 Cyclic adhesion inhibitors |
| 03/31/1999 | EP0904098A1 Compositions comprising antifungal agent and acetate buffer |
| 03/31/1999 | EP0904096A1 Cyclic polypeptides comprising a thioether linkage and methods for their preparation |
| 03/31/1999 | EP0904095A1 Chimeric isoprenoid synthases and uses thereof |
| 03/31/1999 | EP0762886A4 Icam-1/lfa-1 short-chain peptides and method of using same |
| 03/31/1999 | CN1212703A Chromatographic process for obtaining very pure cycloporin A and related cyclosporins |
| 03/30/1999 | US5889165 Photolabile nucleoside protecting groups |
| 03/30/1999 | US5889147 Bromo-tryptophan conopeptides |
| 03/30/1999 | US5889146 Method for synthesis of bifunctional chelating agents-peptides |
| 03/30/1999 | US5888978 Method for reducing the severity of gastro-intestinal damage |
| 03/30/1999 | US5888971 Macrocyclic peptides useful in the treatment of thrombin related disorders |
| 03/30/1999 | US5888970 Technetium-99m labeled chelator incorporated cyclic peptides that bind to the GPIIb/IIIa receptor as imaging agents |
| 03/30/1999 | US5888969 Crohn*s disease |
| 03/30/1999 | US5888512 Human leukocyte antigen peptides which can inhibit cytotoxic t-lymphocyte activity |
| 03/30/1999 | US5888474 Technetium-99m labeled peptides for GPIIb/IIIa ligands useful for thrombus imaging |
| 03/30/1999 | CA2202037C Process for manufacturing cyclosporin a by highly productive fusant strain |
| 03/30/1999 | CA2157927C Therapeutic uses of bactericidal/permeability increasing protein produc ts |
| 03/30/1999 | CA1340472C Universal t-cell epitope derived from p. faciparum circumsporosoite protein |
| 03/25/1999 | WO1999014232A1 A peptide with an affinity for clotting factor viii |
| 03/25/1999 | WO1999014231A2 Bifidus stimulating peptides and its uses |
| 03/25/1999 | WO1999013907A2 Methods to improve immunogenicity of antigens and specificity of antibodies |
| 03/25/1999 | WO1999013899A1 Peptides and peptidomimetics for inhibiting complement activation |
| 03/25/1999 | WO1998057994A3 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
| 03/25/1999 | WO1998051330A9 Method and compositions for treating hyperlipidemia and other conditions |
| 03/25/1999 | CA2303775A1 Methods to improve immunogenicity of antigens and specificity of antibodies |
| 03/24/1999 | EP0902839A1 Method for inhibiting adenylosuccinate synthetase activity methylthioadenosine phosphorylase deficient cells |
| 03/24/1999 | EP0788512B1 Proinsulin peptide compounds for detecting and treating type i diabetes |
| 03/24/1999 | CN1211991A Compounds with growth hormone releasing properties |
| 03/23/1999 | US5886150 Peptides capable of binding to the GAP protein SH3 domain, nucleotide sequences coding therefor, and preparation and use thereof |
| 03/23/1999 | US5886147 Compounds useful for the synthesis of dolastatin analogs |
| 03/23/1999 | US5885966 Immunological castration; (lhrh-luteinizing hormone releasing hormone) |
| 03/23/1999 | US5885782 Microbiocide oligopeptide mixture comprising at least two amino acid sequences; fungicides for treating plant or human |
| 03/23/1999 | US5885768 Immunogenic peptides derived from the orf1, orf2, and orf3 regions of hepatitis e virus (hev), diagnostic reagents containing the peptide antigens, vaccine compositions containing the antigens, antibodies |
| 03/23/1999 | CA1340459C Method to produce immunodiagnostic reagents |
| 03/18/1999 | WO1999013329A1 Methods of identifying molecules that home to angiogenic vasculature in tumors |
| 03/18/1999 | WO1999012969A1 Treatment of obesity |
| 03/18/1999 | WO1999012968A2 Chemokine peptides, variants, derivatives and analogs, their use in methods to inhibit or augment an inflammatory response |
| 03/18/1999 | WO1999012967A1 Retro-inverso neurotrophic and analgesic peptides |
| 03/18/1999 | WO1999012962A1 Inhibitors of phosphoserine and phosphothreonine-proline-specific isomerases |